title: Modulation of ischemic signal by antagonists of N-methyl-D-aspartate, nitric oxide synthase, and platelet-activating factor in gerbil hippocampus.
abstract: Cerebral ischemia in the gerbil results in early hippocampal changes, which include transient activation and/or translocation of protein kinase C (PKC), increased enzymatic activity of ornithine decarboxylase (ODC), and elevated DNA binding ability of activator protein-1 (AP1). The time-course of all three of these postischemic responses was found to be almost parallel, peaking at 3 hr after the ischemic insult. The effectiveness of known modulators of postischemic morphological outcome (MK-801, L-NAME, and gingkolides BN 52020 and BN 52021) in counteracting the induction of PKC, ODC, and AP1 formation was tested. These drugs were administrated as followed: MK-801 (a noncompetitive inhibitor of NMDA channel), 0.8 mg/kg i.p., 30 min before ischemia, and 5 min after the insult; L-NAME (competitive inhibitor of NO synthase), 10 mg/kg i.p., 30 min before ischemia, and 5 mg/kg, 5 min after ischemia; BN52020 and BN52021 (inhibitors of platelet-activating factor: PAF receptors) were administered as a suspension in 5% ethanol in water by oral route, 10 mg/kg for 3 days before ischemia. Three of these drugs, MK-801, L-NAME, and BN52021, significantly reduced ischemia-elevated activity of PKC and ODC, whereas AP1 formation was only partially attenuated. Our observations implicate the existence of different mechanism(s) for postischemic PKC and ODC activation, which in turn is engaged in AP1 induction.
authors.affiliation: Department of Neurochemistry, Polish Academy of Sciences, Warsaw.
authors.forename: B
authors.initials: B
authors.lastname: Zabłocka
authors.forename: K
authors.initials: K
authors.lastname: Lukasiuk
authors.forename: J W
authors.initials: JW
authors.lastname: Lazarewicz
authors.forename: K
authors.initials: K
authors.lastname: Domańska-Janik
mesh_terms: D000818:Animals; D001792:Blood Platelets; D002545:Brain Ischemia / Q000473:pathology*; D004195:Disease Models, Animal; D016291:Dizocilpine Maleate / Q000494:pharmacology; D005849:Gerbillinae; D006624:Hippocampus / Q000473:pathology*; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D009569:Nitric Oxide / Q000494:pharmacology*; D011493:Protein Kinase C; D018808:Transcription Factor AP-1
chemical_list: D018808:Transcription Factor AP-1; D009569:Nitric Oxide; D016202:N-Methylaspartate; D016291:Dizocilpine Maleate; D011493:Protein Kinase C